ArticleBiochemia medica2025
Proposal for delta check limits of frequently requested hormones using real-world data.
Article in Biochemia medica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Essential Data Elements for Laboratory Test Interoperability: An Expert Consensus-Based Framework.Annals of laboratory medicine · 2026Guideline
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Research on delta check limits (DCLs) for hormones is limited, yet some laboratories apply arbitrary DCLs. We aimed to propose DCLs for commonly requested hormones. Materials and methods: This study analyzed 59,657 paired results for adrenocorticotropic hormone (ACTH), cortisol, parathyroid hormone (PTH), prolactin, insulin, testosterone, and thyroglobulin from five Korean university hospitals. Delta check limits were established using the absolute delta difference (absDD) and absolute delta percent change (absDPC) with 5% cutoff for inpatients/emergencies (IE), outpatients (O) and both (combined; mean of them). Proportions outside the DCLs were compared across groups. Results: Using absDD and absDPC, each group's DCLs showed 4.3% to 6.4% of values outside the DCLs, aligning with the 5% cutoff (excluding group IE for insulin, testosterone, and thyroglobulin due to < 1000 data pairs). Delta check limits of absDD differed between groups for ACTH, cortisol, PTH, and prolactin, while for absDPC, differences were seen only for ACTH and prolactin. Cross-validation revealed IE and O groups differed outside DCLs of absDD for ACTH, cortisol, and PTH, but only ACTH with absDPC. Combined DCLs of absDD showed ACTH and cortisol exceeded limits in 7.2% and 9.0% in IE, but only 2.6% and 0.6% in O. With absDPC, ACTH differed (10.4% in IE, 2.8% in O), while cortisol, PTH, and prolactin ranged from 4.0% to 6.1%. Conclusions: Combined DCLs of absDPC are recommended for cortisol, PTH, and prolactin, while ACTH requires separate DCLs on clinical settings. These DCLs from real-world data provide a foundation for establishing DCLs of hormones in clinical laboratories.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.